In the rapidly evolving landscape of modern medicine, few fields offer as much promise—or as much complexity—as...
Seoul, South Korea – [Insert Date] – Liminatus Pharma, a biopharmaceutical company focused on developing novel therapies...
After a meteoric rise that saw venture capital funding for women’s health startups reach record-breaking heights in...
In a significant breakthrough for oncology, researchers at The Institute of Cancer Research (ICR) in London have...
In the high-stakes world of infectious disease drug development, the “holy grail” is a universal treatment—a single...
By BioPharma Dive Editorial Team Published August 24, 2026 As the global population ages, the challenge of...
As of August 6, 2026, the American judicial system remains the primary battleground for reproductive autonomy. Four...
New York, NY – For decades, the role of regulatory T (Treg) cells in cancer has presented...
In the high-stakes theater of global pharmaceuticals, few companies have experienced a rise and fall as dizzying...
In a landmark development for neurodegenerative medicine, Roche has announced that its Elecsys pTau217 blood test has...
